<DOC>
	<DOC>NCT01903070</DOC>
	<brief_summary>This is a bi-centric, prospective, open study comparing the effects of linagliptin on active GLP-1 concentrations in subjects with renal impairment compared to subjects with normal renal function.</brief_summary>
	<brief_title>Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Have Type 2 diabetes mellitus based on the disease diagnostic criteria (WHO) classification Subjects with type 1 diabetes, maturity onset diabetes of the young (MODY) or secondary forms of diabetes such as due to pancreatitis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>